AstraZeneca’s AZD3480 progresses in ADHD
July 11, 2009Sales and Marketing ADHD, Alzheimer's, Alzheimer's ADHD, AstraZeneca
AstraZeneca is to progress its AZD3480 (TC-1734) for attention deficit/hyperactivity disorder (ADHD) and has agreed to make a $10 million …
Adventis Health launches brand competition
July 10, 2009Medical Communications Adventis
Adventis Health has celebrated its official launch as a fully integrated healthcare communications agency. To mark this milestone, the company …
Pfizer to set up new lab in Ireland
July 10, 2009Manufacturing and Production Europe, Ireland, Pfizer
Pfizer has earmarked an 11 million euro investment for a new kilo-scale R&D facility at its manufacturing facility in Ringaskiddy, …
Biopharma company contributes to GSK’s ‘patent pool’
July 10, 2009Research and Development Orphan
Biopharma company Alnylam Pharmaceuticals is to put some of its intellectual property at the disposal of researchers into neglected tropical …
NICE to reconsider GSK’s Tyverb
July 9, 2009Research and Development, Sales and Marketing GSK, NICE, Tyverb
NICE is to reconsider Tyverb under its new lenient approach for end-of-life drugs, after GSK appealed its previous rejection of …
Victoza launched in UK
July 9, 2009Sales and Marketing Victoza, diabetes
Novo Nordisk this week launched its much-anticipated type II diabetes treatment Victoza in the UK. Victoza (liraglutide) is the first …
New clients for Cegedim Dendrite
July 9, 2009Medical Communications Cegedim
Cegedim Dendrite, a leading provider of CRM software and healthcare data to the pharma industry, has announced significant growth over …
Writing on the wall for ‘pay to delay’ generics deals
July 9, 2009Research and Development, Sales and Marketing FDA, US, generics
Deals allowing US pharma companies to pay generics competitors to delay the launch of rival products should be ended, according …
Genzyme’s woes are a boost for Shire and Protalix
July 9, 2009Research and Development, Sales and Marketing FDA, Genzyme, US
The contamination problems at a plant used by Genzyme to manufacture a drug for Gaucher disease have prompted the US …
Europe launches pharma competition crackdown
July 8, 2009Research and Development Europe, generics
The European Union's competition watchdog has declared a crackdown on pharma industry competition, promising scrutiny of deals which it says …
Eisai opens new European HQ in the UK
July 8, 2009Manufacturing and Production, Research and Development, Sales and Marketing Eisai, Europe, HQ
Eisai has officially opened its new European headquarters in the UK, its biggest-ever single capital investment that will bring teams …
UCB opens new UK biologics research centre
July 8, 2009Research and Development UCB
UCB has officially opened its new biologics research centre in the UK, representing an investment of £25 million for the …
GMP violations at Indian CMO hit UK generics makers
July 8, 2009Manufacturing and Production Asia, India
Eight manufacturers of generic medicines in the UK have been forced to withdraw batches of product from the market because …
Sanofi moves to quell Lantus safety concerns
July 7, 2009Research and Development, Sales and Marketing Lantis, Sanofi-Aventis, diabetes
Sanofi-Aventis has rejected claims of a possible connection between its diabetes treatment Lantus and cancer. The possible link was reported …
Depression warnings for Chantix and Zyban
July 7, 2009Research and Development, Sales and Marketing Chantix, FDA, US, drug safety
Pfizer and GSK's smoking cessations drugs will have to carry strong warnings of depression and other mental health adverse events …
PM Soc’s Digital Media Awards to highlight pioneering work
July 7, 2009Sales and Marketing digi, pm society
UK pharma companies and agencies are being invited to submit entries to the industry's first-ever digital media awards, which aim …
Vasella: on leadership
July 7, 2009Sales and Marketing Novartis, Vasella, leadership, management
Novartis’ chief executive and chairman talks to McKinsey about his personal approach to management and leadership, and examines subjects including …
Pharmaceutical manufacturing: news in brief
July 6, 2009Manufacturing and Production Genzyme, Quotient
Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Genzyme, Caraco, MSD, Rottapharm and Almac Pharma Services, …
NHS expectations ‘artificially inflated’
July 6, 2009NHS, healthcare
Expectations of what the NHS can deliver may be artificially inflated by the government's latest grand plan, according to the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
